PARP1 and chronic obstructive pulmonary disease: In human pulmonary epithelial cells, theophylline treatment inhibited PARP-1, preventing NAD+ depletion [78], and in COPD patients, treatment with prednisolone together with theophylline increased SIRT1 expression [82,83].